FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Strides Pharma Losartan Potassium Tablets Recall

Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, M…

Strides Pharma Inc. · East Brunswick, NJ

Risk level
Class II
Reported by FDA
Jul 12, 2023
Recall ID
D-0895-2023
Check your lot numberHow we source this data

Summary

Strides Pharma recalled Losartan Potassium Tablets starting Jun 26, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0895-2023 on Jul 12, 2023. Reason: Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet. Status: Terminated.

Why it was recalled

Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.

Product description

Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08

Lot numbers, UPCs & expiration codes

Lot#: 7901903A, exp. date 04/2024

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0895-2023
Classification
Class II
Status
Terminated
Recall initiated
Jun 26, 2023
FDA report date
Jul 12, 2023
Quantity
2,700 HDPE Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Strides Pharma Inc.

Original FDA data

Every field from FDA enforcement report D-0895-2023, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
92584
Address
2 Tower Center Blvd Ste 1102
Code information
Lot#: 7901903A, exp. date 04/2024
Postal code
08816-1100
Report date
Jul 12, 2023
Product type
Drugs
Recall number
D-0895-2023
Classification
Class II
Recalling firm
Strides Pharma Inc.
Product quantity
2,700 HDPE Bottles
Termination date
May 15, 2024
Reason for recall
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08
Distribution pattern
Nationwide in the USA.
Recall initiation date
Jun 26, 2023
Initial firm notification
Letter
Center classification date
Jul 6, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0895-2023, published Jul 12, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls